Dr. Miller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 E 98th St
First floor
New York, NY 10029Phone+1 212-241-7958Fax+1 212-241-4460
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 1973 - 1975- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 1970 - 1971
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1968 - 1970
New York University School of MedicineClass of 1968
Certifications & Licensure
FL State Medical License 2020 - Present
NY State Medical License 1969 - 2026
NJ State Medical License 2021 - 2025
NC State Medical License 2020 - 2022
PA State Medical License 2020 - 2022
CA State Medical License 2014 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Evaluation of the Response to Acthar Gel Therapy in Patients Who Failed Intravenous Methylprednisolone (IVMP) for MS Relapses Start of enrollment: 2013 Jul 01
Publications & Presentations
PubMed
- DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial.John R Corboy, Robert J Fox, Gary Cutter, Eric Engebretson, Aaron Miller
Multiple Sclerosis. 2025-01-21 - Dissemination in time as a requirement for diagnosis of multiple sclerosis: Time for a change?Aaron E Miller
Multiple Sclerosis. 2024-04-01 - 31 citationsRisk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-b...John R Corboy, Robert J Fox, Ilya Kister, Gary R Cutter, Charity J Morgan
The Lancet. Neurology. 2023-07-01
Press Mentions
Mount Sinai MS Experts Earn Hope AwardSeptember 24th, 2021- Two Mount Sinai Experts Receive Honors from the National Multiple Sclerosis SocietySeptember 16th, 2021
First Relapsing MS Patient Enrolled in Phase 3 Trial of Mapi Pharma’s Once-Monthly Glatiramer FormulationOctober 30th, 2019- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
